InVivo Biosystems Announces New CEO
Ally Wimberly
InVivo Biosystems appoints Kat McCormick as Chief Executive Officer “I can’t thank the InVivo team and our customers enough for making these last few years
Home > InVivo Biosystems Blog
InVivo Biosystems appoints Kat McCormick as Chief Executive Officer “I can’t thank the InVivo team and our customers enough for making these last few years
The InVivo Biosystems Newsletter is delivered to your inbox bi-weekly,
giving you all of the latest company updates, industry news, and more.
Built on a robust portfolio of CRISPR genome editing patents, InVivo Biosystems has established a comprehensive preclinical discovery and development platform. By leveraging alternative models and proprietary methods, we accelerate go-to-market timelines for pharmaceutical companies and beyond.
